FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating the non-alcoholic fatty liver disease. Increasing a transaminase level to three normal values inclusively requires applying essential phospholipids for 2-3 months twice a year that is followed by using statin 10-20 mg in a combination to ursodeoxycholic acid 15-20 mg/kg for 3-6 months. If the transaminase level exceeds three normal values, the treatment is isolated and includes ursodeoxycholic acid 15-20 mg/kg for 3-6 months.
EFFECT: method enables providing the higher clinical effectiveness of the non-alcoholic fatty liver disease.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
| METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
| METHOD FOR CORRECTION OF CRISIS COURSE OF HYPERTENSIVE DISEASE AND ABDOMINAL OBESITY | 2013 |
|
RU2542462C2 |
| METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
| METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
| METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS OF ALCOHOLIC AETIOLOGY | 2011 |
|
RU2477482C1 |
